Related Experiment Video
Updated: Oct 1, 2025

09:37
Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
2.0K
Waning COVID-19 vaccine effectiveness in Japan
Junko Kurita1, Tamie Sugawara2, Yasushi Ohkusa2
1Department of Nursing, Tokiwa University, Ibaraki, Japan.
Drug Discoveries & Therapeutics
|March 10, 2022
Summary
COVID-19 vaccine effectiveness wanes significantly over time in Japan. Protection from the second vaccine dose was completely lost by 90 to 120 days, indicating a need for booster shots.
Area of Science:
- Epidemiology
- Immunology
- Public Health
Background:
- High COVID-19 vaccine uptake in Japan reached nearly 80% by late 2021.
- Concerns exist regarding the duration of vaccine-induced immunity against SARS-CoV-2.
- The emergence of mutated strains and public events like the Olympic Games complicate effectiveness assessments.
Purpose of the Study:
- To evaluate the waning effectiveness of COVID-19 vaccines in Japan.
- To determine the impact of time since vaccination on protection against COVID-19 transmission.
- To analyze factors influencing vaccine effectiveness, including viral variants and public health interventions.
Main Methods:
- Utilized time-series analysis to model the effective reproduction number (R(t)).
- Incorporated variables such as vaccine coverage (lagged), mutated strain prevalence, and an Olympic Games dummy variable.
- Controlled for environmental factors (temperature, humidity) and mobility data.
Main Results:
- Vaccine coverage more than 90 days prior significantly increased R(t).
- Effectiveness was completely diminished by 90 to 120 days post-vaccination.
- Significant waning of vaccine effectiveness was observed starting 90 days after the second dose.
Conclusions:
- COVID-19 vaccine effectiveness wanes substantially over time in the Japanese population.
- Immunity protection significantly decreases approximately 90 days after the second vaccine dose.
- Findings highlight the critical need for understanding and addressing vaccine durability, potentially through booster programs.
Related Concept Videos
Vaccinations
45.5K
Overview
45.5K
Antimicrobial Effectiveness
248
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
248
Dose-Response Relationship: Potency and Efficacy
5.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.5K
Bias in Epidemiological Studies
748
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
748
Cancer Vaccines
539
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
539

